Abstract
Rat monoclonal antibodies directed against the BALB/c myeloma protein M315 (alpha,lambda 2) are described. 9A8 (IgG1) binds the V domain of lambda 2 and cross-reacts with lambda 1 and lambda 3 chains. 2B6 (IgG2a) is directed to the C domain of lambda 2 and cross-reacts with C lambda 3. The antibodies bind isolated chains as well as complete immunoglobulins. The monoclonals detect soluble immunoglobulin (radioimmunoassay), immunoglobulin immobilized on polystyrene (enzyme-linked immunosorbent assay), immunoglobulin bound to nitrocellulose (immunoblotting), and surface immunoglobulin intercalated in cell membranes (immunofluorescence). The antibodies are easily purified on protein G immunosorbents and may be biotinylated or conjugated with fluorescein isothiocyanate without loss of capacity to bind. In addition to the anti-lambda antibodies, a C alpha 2/C alpha 3-specific monoclonal antibody, 8D2 (IgG2a) is described.
References
Nov 1, 1978·The Journal of Experimental Medicine·T Cotner, H N Eisen
Dec 1, 1978·Cell·O BernardS Tonegawa
Mar 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·S TonegawaW Gilbert
Feb 28, 1978·Biochemical and Biophysical Research Communications·P J Fraker, J C Speck
Mar 1, 1985·European Journal of Immunology·B BogenK Hannestad
May 1, 1987·European Journal of Immunology·R DildropK Rajewsky
Nov 1, 1986·European Journal of Immunology·B BogenW Haas
Nov 1, 1986·European Journal of Immunology·B BogenK Hannestad
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P SanchezP A Cazenave
Aug 15, 1970·Nature·U K Laemmli
Dec 12, 1970·Nature·M G WeigertM Cohn
Jan 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·T AzumaH N Eisen
May 1, 1983·European Journal of Immunology·B BogenK Hannestad
Jul 1, 1984·Molecular Immunology·B Bogen, K Hannestad
Apr 1, 1981·The Journal of Experimental Medicine·P D'EustachioF H Ruddle
Jun 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·J MillerU Storb
Jul 22, 1982·Nature·A L BothwellD Baltimore
Jan 1, 1983·Hybridoma·S WeissM Cohn
Jun 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·B BlombergS Tonegawa
Feb 4, 1982·Nature·J MillerU Storb
Jan 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·B Blomberg, S Tonegawa
Oct 7, 1982·Nature·B W ElliottL A Steiner
Aug 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·E SelsingU Storb
Jan 1, 1981·Hybridoma·D E YeltonM D Scharff
Citations
Feb 8, 2005·Cancer Immunology, Immunotherapy : CII·Katrin U LundinBjarne Bogen
Jul 1, 1991·Molecular Immunology·A J GeorgeF K Stevenson
Apr 1, 1990·Veterinary Immunology and Immunopathology·J Hopkins, B M Dutia
Jan 13, 2010·Immunology and Cell Biology·Johanne T JacobsenBjarne Bogen
Mar 21, 2001·The Journal of Experimental Medicine·T Sun, U Storb
Apr 1, 1991·Hybridoma·A J GeorgeF K Stevenson
Jun 1, 1991·Scandinavian Journal of Immunology·G F Lauritzsen, B Bogen
Jul 25, 2006·Molecular Immunology·Veronica V VolginaUrsula Storb
Aug 26, 1998·European Journal of Immunology·H EngelS Weiss
Aug 4, 1994·Nature·J MelnickY Argon
Oct 1, 1991·European Journal of Immunology·B Bogen, S Weiss
Jul 31, 1999·European Journal of Immunology·H EngelS Weiss
Jul 7, 2017·The Cochrane Database of Systematic Reviews·Chantal ArditiBernard Burnand
Jul 20, 2007·The Cochrane Database of Systematic Reviews·M E J L HulscherR Grol
Oct 1, 1990·European Journal of Immunology·B BogenS Weiss
Jul 2, 2009·Cancer Research·Alexandre CorthayBjarne Bogen